Global Biosimilar Monoclonal Antibodies Market Outlook 2022

Global Biosimilar Monoclonal Antibodies Market Outlook 2022

Table of Contents
1 Biosimilar Monoclonal Antibodies Market Overview
1.1 Product Overview and Scope of Biosimilar Monoclonal Antibodies
1.2 Biosimilar Monoclonal Antibodies Segment by Type
1.2.1 Global Biosimilar Monoclonal Antibodies Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Infliximab
1.2.3 Rituximab
1.2.4 Trastuzumab
1.2.5 Adalimumab
1.2.6 Other
1.3 Biosimilar Monoclonal Antibodies Segment by Application
1.3.1 Global Biosimilar Monoclonal Antibodies Sales Comparison by Application: (2021-2027)
1.3.2 Oncology
1.3.3 Autoimmune Disease
1.3.4 Other
1.4 Global Biosimilar Monoclonal Antibodies Market Size Estimates and Forecasts
1.4.1 Global Biosimilar Monoclonal Antibodies Revenue 2016-2027
1.4.2 Global Biosimilar Monoclonal Antibodies Sales 2016-2027
1.4.3 Biosimilar Monoclonal Antibodies Market Size by Region: 2016 Versus 2021 Versus 2027
2 Biosimilar Monoclonal Antibodies Market Competition by Manufacturers
2.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturers (2016-2021)
2.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Biosimilar Monoclonal Antibodies Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Biosimilar Monoclonal Antibodies Manufacturing Sites, Area Served, Product Type
2.5 Biosimilar Monoclonal Antibodies Market Competitive Situation and Trends
2.5.1 Biosimilar Monoclonal Antibodies Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biosimilar Monoclonal Antibodies Players Market Share by Revenue
2.5.3 Global Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biosimilar Monoclonal Antibodies Retrospective Market Scenario by Region
3.1 Global Biosimilar Monoclonal Antibodies Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Biosimilar Monoclonal Antibodies Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Biosimilar Monoclonal Antibodies Market Facts & Figures by Country
3.3.1 North America Biosimilar Monoclonal Antibodies Sales by Country
3.3.2 North America Biosimilar Monoclonal Antibodies Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biosimilar Monoclonal Antibodies Market Facts & Figures by Country
3.4.1 Europe Biosimilar Monoclonal Antibodies Sales by Country
3.4.2 Europe Biosimilar Monoclonal Antibodies Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biosimilar Monoclonal Antibodies Market Facts & Figures by Region
3.5.1 Asia Pacific Biosimilar Monoclonal Antibodies Sales by Region
3.5.2 Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Biosimilar Monoclonal Antibodies Market Facts & Figures by Country
3.6.1 Latin America Biosimilar Monoclonal Antibodies Sales by Country
3.6.2 Latin America Biosimilar Monoclonal Antibodies Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Biosimilar Monoclonal Antibodies Market Facts & Figures by Country
3.7.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Country
3.7.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Biosimilar Monoclonal Antibodies Historic Market Analysis by Type
4.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2016-2021)
4.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2016-2021)
4.3 Global Biosimilar Monoclonal Antibodies Price by Type (2016-2021)
5 Global Biosimilar Monoclonal Antibodies Historic Market Analysis by Application
5.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2016-2021)
5.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2016-2021)
5.3 Global Biosimilar Monoclonal Antibodies Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Celltrion
6.1.1 Celltrion Corporation Information
6.1.2 Celltrion Description and Business Overview
6.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Celltrion Biosimilar Monoclonal Antibodies Product Portfolio
6.1.5 Celltrion Recent Developments/Updates
6.2 Pfizer (Hospira)
6.2.1 Pfizer (Hospira) Corporation Information
6.2.2 Pfizer (Hospira) Description and Business Overview
6.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product Portfolio
6.2.5 Pfizer (Hospira) Recent Developments/Updates
6.3 3SBIO
6.3.1 3SBIO Corporation Information
6.3.2 3SBIO Description and Business Overview
6.3.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.3.4 3SBIO Biosimilar Monoclonal Antibodies Product Portfolio
6.3.5 3SBIO Recent Developments/Updates
6.4 Novartis (Sandoz)
6.4.1 Novartis (Sandoz) Corporation Information
6.4.2 Novartis (Sandoz) Description and Business Overview
6.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product Portfolio
6.4.5 Novartis (Sandoz) Recent Developments/Updates
6.5 Dr Reddy's
6.5.1 Dr Reddy's Corporation Information
6.5.2 Dr Reddy's Description and Business Overview
6.5.3 Dr Reddy's Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Dr Reddy's Biosimilar Monoclonal Antibodies Product Portfolio
6.5.5 Dr Reddy's Recent Developments/Updates
6.6 Celgen Biopharma
6.6.1 Celgen Biopharma Corporation Information
6.6.2 Celgen Biopharma Description and Business Overview
6.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Celgen Biopharma Biosimilar Monoclonal Antibodies Product Portfolio
6.6.5 Celgen Biopharma Recent Developments/Updates
6.7 Cadila Healthcare
6.6.1 Cadila Healthcare Corporation Information
6.6.2 Cadila Healthcare Description and Business Overview
6.6.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Cadila Healthcare Biosimilar Monoclonal Antibodies Product Portfolio
6.7.5 Cadila Healthcare Recent Developments/Updates
6.8 Hisun Pharma
6.8.1 Hisun Pharma Corporation Information
6.8.2 Hisun Pharma Description and Business Overview
6.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Hisun Pharma Biosimilar Monoclonal Antibodies Product Portfolio
6.8.5 Hisun Pharma Recent Developments/Updates
6.9 Torrent Pharmaceuticals
6.9.1 Torrent Pharmaceuticals Corporation Information
6.9.2 Torrent Pharmaceuticals Description and Business Overview
6.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product Portfolio
6.9.5 Torrent Pharmaceuticals Recent Developments/Updates
7 Biosimilar Monoclonal Antibodies Manufacturing Cost Analysis
7.1 Biosimilar Monoclonal Antibodies Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
7.4 Biosimilar Monoclonal Antibodies Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biosimilar Monoclonal Antibodies Distributors List
8.3 Biosimilar Monoclonal Antibodies Customers
9 Biosimilar Monoclonal Antibodies Market Dynamics
9.1 Biosimilar Monoclonal Antibodies Industry Trends
9.2 Biosimilar Monoclonal Antibodies Growth Drivers
9.3 Biosimilar Monoclonal Antibodies Market Challenges
9.4 Biosimilar Monoclonal Antibodies Market Restraints
10 Global Market Forecast
10.1 Biosimilar Monoclonal Antibodies Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biosimilar Monoclonal Antibodies by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Biosimilar Monoclonal Antibodies by Type (2022-2027)
10.2 Biosimilar Monoclonal Antibodies Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biosimilar Monoclonal Antibodies by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Biosimilar Monoclonal Antibodies by Application (2022-2027)
10.3 Biosimilar Monoclonal Antibodies Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biosimilar Monoclonal Antibodies by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Biosimilar Monoclonal Antibodies by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Biosimilar Monoclonal Antibodies Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Biosimilar Monoclonal Antibodies Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Biosimilar Monoclonal Antibodies Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Biosimilar Monoclonal Antibodies Covered in This Study
Table 5. Global Biosimilar Monoclonal Antibodies Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Biosimilar Monoclonal Antibodies Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Biosimilar Monoclonal Antibodies Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Biosimilar Monoclonal Antibodies Manufacturing Sites and Area Served
Table 11. Manufacturers Biosimilar Monoclonal Antibodies Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Biosimilar Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Monoclonal Antibodies as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Biosimilar Monoclonal Antibodies Sales by Region (2016-2021) & (K Units)
Table 16. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2016-2021)
Table 17. Global Biosimilar Monoclonal Antibodies Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Biosimilar Monoclonal Antibodies Sales by Country (2016-2021) & (K Units)
Table 19. North America Biosimilar Monoclonal Antibodies Sales Market Share by Country (2016-2021)
Table 20. North America Biosimilar Monoclonal Antibodies Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2016-2021)
Table 22. Europe Biosimilar Monoclonal Antibodies Sales by Country (2016-2021) & (K Units)
Table 23. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Country (2016-2021)
Table 24. Europe Biosimilar Monoclonal Antibodies Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Biosimilar Monoclonal Antibodies Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2016-2021)
Table 30. Latin America Biosimilar Monoclonal Antibodies Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Biosimilar Monoclonal Antibodies Sales Market Share by Country (2016-2021)
Table 32. Latin America Biosimilar Monoclonal Antibodies Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2016-2021)
Table 38. Global Biosimilar Monoclonal Antibodies Sales (K Units) by Type (2016-2021)
Table 39. Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2016-2021)
Table 40. Global Biosimilar Monoclonal Antibodies Revenue (Million US$) by Type (2016-2021)
Table 41. Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2016-2021)
Table 42. Global Biosimilar Monoclonal Antibodies Price (USD/Unit) by Type (2016-2021)
Table 43. Global Biosimilar Monoclonal Antibodies Sales (K Units) by Application (2016-2021)
Table 44. Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2016-2021)
Table 45. Global Biosimilar Monoclonal Antibodies Revenue (Million US$) by Application (2016-2021)
Table 46. Global Biosimilar Monoclonal Antibodies Revenue Share by Application (2016-2021)
Table 47. Global Biosimilar Monoclonal Antibodies Price (USD/Unit) by Application (2016-2021)
Table 48. Celltrion Corporation Information
Table 49. Celltrion Description and Business Overview
Table 50. Celltrion Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Celltrion Biosimilar Monoclonal Antibodies Product
Table 52. Celltrion Recent Developments/Updates
Table 53. Pfizer (Hospira) Corporation Information
Table 54. Pfizer (Hospira) Description and Business Overview
Table 55. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product
Table 57. Pfizer (Hospira) Recent Developments/Updates
Table 58. 3SBIO Corporation Information
Table 59. 3SBIO Description and Business Overview
Table 60. 3SBIO Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. 3SBIO Biosimilar Monoclonal Antibodies Product
Table 62. 3SBIO Recent Developments/Updates
Table 63. Novartis (Sandoz) Corporation Information
Table 64. Novartis (Sandoz) Description and Business Overview
Table 65. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product
Table 67. Novartis (Sandoz) Recent Developments/Updates
Table 68. Dr Reddy's Corporation Information
Table 69. Dr Reddy's Description and Business Overview
Table 70. Dr Reddy's Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Dr Reddy's Biosimilar Monoclonal Antibodies Product
Table 72. Dr Reddy's Recent Developments/Updates
Table 73. Celgen Biopharma Corporation Information
Table 74. Celgen Biopharma Description and Business Overview
Table 75. Celgen Biopharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Celgen Biopharma Biosimilar Monoclonal Antibodies Product
Table 77. Celgen Biopharma Recent Developments/Updates
Table 78. Cadila Healthcare Corporation Information
Table 79. Cadila Healthcare Description and Business Overview
Table 80. Cadila Healthcare Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Cadila Healthcare Biosimilar Monoclonal Antibodies Product
Table 82. Cadila Healthcare Recent Developments/Updates
Table 83. Hisun Pharma Corporation Information
Table 84. Hisun Pharma Description and Business Overview
Table 85. Hisun Pharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Hisun Pharma Biosimilar Monoclonal Antibodies Product
Table 87. Hisun Pharma Recent Developments/Updates
Table 88. Torrent Pharmaceuticals Corporation Information
Table 89. Torrent Pharmaceuticals Description and Business Overview
Table 90. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product
Table 92. Torrent Pharmaceuticals Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Biosimilar Monoclonal Antibodies Distributors List
Table 96. Biosimilar Monoclonal Antibodies Customers List
Table 97. Biosimilar Monoclonal Antibodies Market Trends
Table 98. Biosimilar Monoclonal Antibodies Growth Drivers
Table 99. Biosimilar Monoclonal Antibodies Market Challenges
Table 100. Biosimilar Monoclonal Antibodies Market Restraints
Table 101. Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2022-2027) & (K Units)
Table 102. Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Type (2022-2027)
Table 103. Global Biosimilar Monoclonal Antibodies Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 104. Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Type (2022-2027)
Table 105. Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2022-2027) & (K Units)
Table 106. Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Application (2022-2027)
Table 107. Global Biosimilar Monoclonal Antibodies Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 108. Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Application (2022-2027)
Table 109. Global Biosimilar Monoclonal Antibodies Sales Forecast by Region (2022-2027) & (K Units)
Table 110. Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Region (2022-2027)
Table 111. Global Biosimilar Monoclonal Antibodies Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 112. Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Region (2022-2027)
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biosimilar Monoclonal Antibodies
Figure 2. Global Biosimilar Monoclonal Antibodies Market Share by Type in 2020 & 2027
Figure 3. Infliximab Product Picture
Figure 4. Rituximab Product Picture
Figure 5. Trastuzumab Product Picture
Figure 6. Adalimumab Product Picture
Figure 7. Other Product Picture
Figure 8. Global Biosimilar Monoclonal Antibodies Market Share by Application in 2020 & 2027
Figure 9. Oncology
Figure 10. Autoimmune Disease
Figure 11. Other
Figure 12. Global Biosimilar Monoclonal Antibodies Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Biosimilar Monoclonal Antibodies Market Size 2016-2027 (US$ Million)
Figure 14. Global Biosimilar Monoclonal Antibodies Sales 2016-2027 (K Units)
Figure 15. Global Biosimilar Monoclonal Antibodies Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Biosimilar Monoclonal Antibodies Sales Share by Manufacturers in 2020
Figure 17. Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Biosimilar Monoclonal Antibodies Players: Market Share by Revenue in 2020
Figure 19. Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2016-2021)
Figure 21. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region in 2020
Figure 22. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2016-2021)
Figure 23. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region in 2020
Figure 24. U.S. Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Biosimilar Monoclonal Antibodies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Biosimilar Monoclonal Antibodies by Type (2016-2021)
Figure 49. Sales Market Share of Biosimilar Monoclonal Antibodies by Application (2016-2021)
Figure 50. Sales Market Share of Biosimilar Monoclonal Antibodies by Application in 2020
Figure 51. Revenue Share of Biosimilar Monoclonal Antibodies by Application (2016-2021)
Figure 52. Revenue Share of Biosimilar Monoclonal Antibodies by Application in 2020
Figure 53. Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
Figure 54. Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
Figure 55. Biosimilar Monoclonal Antibodies Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs